This report provides a financial analysis of Hikma Pharmaceutical Plc including ratio analysis, profitability ratios, liquidity ratios, and gearing ratios. The report also includes advantages and limitations of ratio analysis. The performance of the company over the last 4 years are deteriorating. Except the liquidity position, the company’s gearing position as well as the profitability position during the year 2017 were significantly lower. Moreover, during the year 2017 the company did not have any positive earnings to cover up any further expenses or creating returns to the shareholders.